The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes

Related Experiment Video

Updated: Apr 12, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

14.1K

E Idzkowska1, A Eljaszewicz2, P Miklasz2

  • 1Department of Cardiology, Medical University of Bialystok, Poland.

Scandinavian Journal of Immunology
|May 23, 2015
PubMed

Insights

Different monocyte subsets play key roles in cardiovascular disease. Understanding classical, intermediate, and non-classical monocytes offers insights into atherosclerosis and acute coronary syndromes, potentially revealing new biomarkers and therapeutic targets.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Biology

Background:

  • Inflammation is central to atherosclerosis and acute coronary syndromes.
  • Monocytes are key inflammatory cells, but their subsets have distinct roles.
  • Monocyte subsets are classified by CD14 and CD16 expression: classical (CD14++CD16-), intermediate (CD14++CD16+), and non-classical (CD14+CD16++).

Purpose of the Study:

  • To review the complex roles of distinct monocyte subsets in atherosclerosis.
  • To summarize monocyte subset involvement in acute coronary syndromes.
  • To explore the potential of monocyte subsets as cardiovascular risk biomarkers and therapeutic targets.

Main Methods:

  • Literature review of current research on monocyte subsets.
  • Analysis of functional differences between monocyte subsets in cardiovascular contexts.
  • Synthesis of data on biomarker and therapeutic potential.

Main Results:

  • Monocyte subsets exhibit differential functions in atherosclerotic plaque development and healing.
  • Specific monocyte subsets are implicated in the pathogenesis of atherosclerosis and acute coronary syndromes.
  • Evidence suggests certain monocyte subsets may serve as predictive biomarkers for cardiovascular risk.

Conclusions:

  • Distinct monocyte subsets have specialized roles in cardiovascular disease.
  • Targeting specific monocyte subsets may offer novel therapeutic strategies for atherosclerosis and its complications.
  • Further research into monocyte subsets could lead to improved cardiovascular risk prediction and treatment.

More Related Videos

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

10.2K
Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis09:12

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis

Published on: October 17, 2018

59.6K

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
783
Inflammation01:38

Inflammation

Overview
65.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
465
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K